This secondary analysis of the ATHENA trial looked beyond radiation type to predictors of post-RT cognition in patients with brain metastases. On multivariable analysis, only poor KPS and systemic progression predicted cognitive decline. Neither RT technique or systemic therapy had as significant an effect. | Perlow, ASTRO 2025
